DBI, CMO for sterile forms

DBI has built a site which meets international standards and guidelines and so allows the production of drugs for human use, with guaranteed quality.

DBI is a pharmaceutical company (ANSM License M 12/203), dedicated to providing a small‑scale production site
for pre-commercial batches (pre-clinical, clinical and pilot) of injectable – liquid or lyophilized – drug products under isolators.

The benefits of DBI meet the needs of biotechnology and pharmaceutical companies, including major groups,
for producing small injectable batches within a GMP production’s site.

ENTER